Related Content
Search Google Scholar for:
|
|
Science 15 July 1994: Vol. 265. no. 5170, pp. 386 - 391 DOI: 10.1126/science.8023159
|
|
Articles
Science, Vol 265, Issue 5170, 386-391
Copyright © 1994 by American Association for the Advancement of Science
High-resolution structure of the oligomerization domain of p53 by multidimensional NMR
GM Clore,
JG Omichinski,
K Sakaguchi,
N Zambrano,
H Sakamoto,
E Appella,
and
AM Gronenborn
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
The three-dimensional structure of the oligomerization domain (residues 319 to 360) of the tumor suppressor p53 has been solved by multidimensional heteronuclear magnetic resonance (NMR) spectroscopy. The domain forms a 20-kilodalton symmetric tetramer with a topology made up from a dimer of dimers. The two primary dimers each comprise two antiparallel helices linked by an antiparallel beta sheet. One beta strand and one helix are contributed from each monomer. The interface between the two dimers forming the tetramer is mediated solely by helix-helix contacts. The overall result is a symmetric, four-helix bundle with adjacent helices oriented antiparallel to each other and with the two antiparallel beta sheets located on opposing faces of the molecule. The tetramer is stabilized not only by hydrophobic interactions within the protein core but also by a number of electrostatic interactions. The implications of the structure of the tetramer for the biological function of p53 are discussed.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Functional four-base A/T gap core sequence CATTAG of P53 response elements specifically bound tetrameric P53 differently than two-base A/T gap core sequence CATG bound both dimeric and tetrameric P53.
- B.-H. Cai, J.-Y. Chen, M.-H. Lu, L.-T. Chang, H.-C. Lin, Y.-M. Chang, and C.-F. Chao (2009)
Nucleic Acids Res.
37, 1984-1990
| Abstract »
| Full Text »
| PDF »
- p53 Oligomerization Is Essential for Its C-terminal Lysine Acetylation.
- Y. Itahana, H. Ke, and Y. Zhang (2009)
J. Biol. Chem.
284, 5158-5164
| Abstract »
| Full Text »
| PDF »
- Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 ORF50/Rta Lytic Switch Protein Functions as a Tetramer.
- W. Bu, K. D. Carroll, D. Palmeri, and D. M. Lukac (2007)
J. Virol.
81, 5788-5806
| Abstract »
| Full Text »
| PDF »
- The Effects of Mutations at Position 253 on the Thermostability of the Bacillus subtilis 3-Isopropylmalate Dehydrogenase Subunit Interface.
- T. Ohkuri and A. Yamagishi (2007)
J. Biochem.
141, 791-797
| Abstract »
| Full Text »
| PDF »
- Structural Basis for p53 Binding-induced DNA Bending.
- Y. Pan and R. Nussinov (2007)
J. Biol. Chem.
282, 691-699
| Abstract »
| Full Text »
| PDF »
- Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system..
- K. J.-L. RILEY, L. A. CASSIDAY, A. KUMAR, and L. J. MAHER III (2006)
RNA
12, 620-630
| Abstract »
| Full Text »
| PDF »
- Structural Details on mdm2-p53 Interaction.
- S.-W. Chi, S.-H. Lee, D.-H. Kim, M.-J. Ahn, J.-S. Kim, J.-Y. Woo, T. Torizawa, M. Kainosho, and K.-H. Han (2005)
J. Biol. Chem.
280, 38795-38802
| Abstract »
| Full Text »
| PDF »
- Structure of {lambda} CII: Implications for recognition of direct-repeat DNA by an unusual tetrameric organization.
- A. B. Datta, S. Panjikar, M. S. Weiss, P. Chakrabarti, and P. Parrack (2005)
PNAS
102, 11242-11247
| Abstract »
| Full Text »
| PDF »
- Comparison of the protein-protein interfaces in the p53-DNA crystal structures: Towards elucidation of the biological interface.
- B. Ma, Y. Pan, K. Gunasekaran, R. B. Venkataraghavan, A. J. Levine, and R. Nussinov (2005)
PNAS
102, 3988-3993
| Abstract »
| Full Text »
| PDF »
- Binding of Rad51 and Other Peptide Sequences to a Promiscuous, Highly Electrostatic Binding Site in p53.
- A. Friedler, D. B. Veprintsev, T. Rutherford, K. I. von Glos, and A. R. Fersht (2005)
J. Biol. Chem.
280, 8051-8059
| Abstract »
| Full Text »
| PDF »
- Analysis and prediction of leucine-rich nuclear export signals.
- T. la Cour, L. Kiemer, A. Molgaard, R. Gupta, K. Skriver, and S. Brunak (2004)
Protein Eng. Des. Sel.
17, 527-536
| Abstract »
| Full Text »
| PDF »
- Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
- S. Kato, S.-Y. Han, W. Liu, K. Otsuka, H. Shibata, R. Kanamaru, and C. Ishioka (2003)
PNAS
100, 8424-8429
| Abstract »
| Full Text »
| PDF »
- Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of Dimers. IMPLICATIONS ON THE DOMINANT NEGATIVE EFFECT.
- C. D. Nicholls, K. G. McLure, M. A. Shields, and P. W. K. Lee (2002)
J. Biol. Chem.
277, 12937-12945
| Abstract »
| Full Text »
| PDF »
- Modeling multi-component protein-DNA complexes: the role of bending and dimerization in the complex of p53 dimers with DNA.
- A. Lebrun, R. Lavery, and H. Weinstein (2001)
Protein Eng. Des. Sel.
14, 233-243
| Abstract »
| Full Text »
| PDF »
- Heterogeneity in the Clinical Phenotype of TP53 Mutations in Breast Cancer Patients.
- J. Alsner, M. Yilmaz, P. Guldberg, L. L. Hansen, and J. Overgaard (2000)
Clin. Cancer Res.
6, 3923-3931
| Abstract »
| Full Text »
- p53 Mutations and Expression in Breast Carcinoma in Situ.
- J. Lukas, N. Niu, and M. F. Press (2000)
Am. J. Pathol.
156, 183-191
| Abstract »
| Full Text »
| PDF »
- An ATP/ADP-Dependent Molecular Switch Regulates the Stability of p53-DNA Complexes.
- A. L. Okorokov and J. Milner (1999)
Mol. Cell. Biol.
19, 7501-7510
| Abstract »
| Full Text »
| PDF »
- Reactivation of Mutant p53 through Interaction of a C-Terminal Peptide with the Core Domain.
- G. Selivanova, L. Ryabchenko, E. Jansson, V. Iotsova, and K. G. Wiman (1999)
Mol. Cell. Biol.
19, 3395-3402
| Abstract »
| Full Text »
| PDF »
- Calcium-dependent Interaction of S100B with the C-terminal Domain of the Tumor Suppressor p53.
- C. Delphin, M. Ronjat, J. C. Deloulme, G. Garin, L. Debussche, Y. Higashimoto, K. Sakaguchi, and J. Baudier (1999)
J. Biol. Chem.
274, 10539-10544
| Abstract »
| Full Text »
| PDF »
- p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage.
- L. Liu, D. M. Scolnick, R. C. Trievel, H. B. Zhang, R. Marmorstein, T. D. Halazonetis, and S. L. Berger (1999)
Mol. Cell. Biol.
19, 1202-1209
| Abstract »
| Full Text »
| PDF »
- p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells.
- C. J. Di Como, C. Gaiddon, and C. Prives (1999)
Mol. Cell. Biol.
19, 1438-1449
| Abstract »
| Full Text »
| PDF »
- A Role for Groucho Tetramerization in Transcriptional Repression.
- G. Chen, P. H. Nguyen, and A. J. Courey (1998)
Mol. Cell. Biol.
18, 7259-7268
| Abstract »
| Full Text »
- Cooperation of a Single Lysine Mutation and a C-terminal Domain in the Cytoplasmic Sequestration of the p53 Protein.
- S.-H. Liang, D. Hong, and M. F. Clarke (1998)
J. Biol. Chem.
273, 19817-19821
| Abstract »
| Full Text »
| PDF »
- Review : p53 in the pathogenesis, diagnosis, and treatment of cancer.
- E. Perz and J. G. Kuhn (1998)
Journal of Oncology Pharmacy Practice
4, 75-102
| Abstract »
| PDF »
- Identification of an additional negative regulatory region for p53 sequence-specific DNA binding.
- B. F. Muller-Tiemann, T. D. Halazonetis, and J. J. Elting (1998)
PNAS
95, 6079-6084
| Abstract »
| Full Text »
| PDF »
- Deletion of the Saccharomyces cerevisiae TRR1 Gene Encoding Thioredoxin Reductase Inhibits p53-dependent Reporter Gene Expression.
- G. D. Pearson and G. F. Merrill (1998)
J. Biol. Chem.
273, 5431-5434
| Abstract »
| Full Text »
| PDF »
- HSP70 Binding Sites in the Tumor Suppressor Protein p53.
- A. M. Fourie, T. R. Hupp, D. P. Lane, B.-C. Sang, M. S. Barbosa, J. F. Sambrook, and M.-J. H. Gething (1997)
J. Biol. Chem.
272, 19471-19479
| Abstract »
| Full Text »
| PDF »
- alpha -Helical Protein Assembly Motifs.
- W. D. Kohn, C. T. Mant, and R. S. Hodges (1997)
J. Biol. Chem.
272, 2583-2586
| Full Text »
| PDF »
- Mouse RAD50 Has Limited Epitopic Homology to p53 and Is Expressed in the Adult Myocardium.
- K. K. Kim, A. I. Daud, S. C. Wong, L. Pajak, S.-C. Tsai, H. Wang, W. J. Henzel, and L. J. Field (1996)
J. Biol. Chem.
271, 29255-29264
| Abstract »
| Full Text »
| PDF »
- Allosteric Regulation of the Thermostability and DNA Binding Activity of Human p53 by Specific Interacting Proteins.
- S. Hansen, T. R. Hupp, and D. P. Lane (1996)
J. Biol. Chem.
271, 3917-3924
| Abstract »
| Full Text »
| PDF »
- Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
- P. Jeffrey, S Gorina, and N. Pavletich (1995)
Science
267, 1498-1502
| Abstract »
| PDF »
- Interhelical angles in the solution structure of the oligomerization domain of p53: correction.
- G. Clore, J. Omichinski, K Sakaguchi, N Zambrano, H Sakamoto, E Appella, and A. Gronenborn (1995)
Science
267, 1515-1516
| PDF »
- CMV-p53 interaction may help explain clogged arteries.
- J Marx (1994)
Science
265, 320
| PDF »
- p53: a glimpse at the puppet behind the shadow play.
- S Friend (1994)
Science
265, 334-335
| PDF »
- p53 Amino Acids 339-346 Represent the Minimal p53 Repression Domain.
- T.-M. Hong, J. J. W. Chen, K. Peck, P.-C. Yang, and C.-W. Wu (2001)
J. Biol. Chem.
276, 1510-1515
| Abstract »
| Full Text »
| PDF »
- NMR Spectroscopy Reveals the Solution Dimerization Interface of p53 Core Domains Bound to Their Consensus DNA.
- C. Klein, E. Planker, T. Diercks, H. Kessler, K.-P. Kunkele, K. Lang, S. Hansen, and M. Schwaiger (2001)
J. Biol. Chem.
276, 49020-49027
| Abstract »
| Full Text »
| PDF »
- Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.
- M. Kanovsky, A. Raffo, L. Drew, R. Rosal, T. Do, F. K. Friedman, P. Rubinstein, J. Visser, R. Robinson, P. W. Brandt-Rauf, et al. (2001)
PNAS
98, 12438-12443
| Abstract »
| Full Text »
| PDF »
|
|